60 related articles for article (PubMed ID: 15938528)
1. [Diagnostic investigations on left ventricular hypertrophy (review of foreign literature for 1962-2003)].
Komarova OA; Gudkova NB; Kotova LA
Ter Arkh; 2005; 77(4):27-30. PubMed ID: 15938528
[No Abstract] [Full Text] [Related]
2. Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients.
da Costa W; Riera AR; Costa Fde A; Bombig MT; de Paola AA; Carvalho AC; Fonseca FH; Luna Filho B; Póvoa R
J Electrocardiol; 2008; 41(6):724-9. PubMed ID: 18954613
[TBL] [Abstract][Full Text] [Related]
3. The importance of methodology: how should we define left ventricular hypertrophy?
Gondoni LA
Am J Cardiol; 2009 Feb; 103(4):574. PubMed ID: 19195524
[No Abstract] [Full Text] [Related]
4. Effect of body mass index on left ventricular cavity size and ejection fraction.
Dorbala S; Crugnale S; Yang D; Di Carli MF
Am J Cardiol; 2006 Mar; 97(5):725-9. PubMed ID: 16490446
[TBL] [Abstract][Full Text] [Related]
5. Combination of electrocardiographic and echocardiographic information identifies individuals prone to a progressive increase in left ventricular mass over 5 years.
Reffelmann T; Dörr M; Völzke H; Kors J; Ruppert J; Robinson D; Felix SB
J Hypertens; 2009 Apr; 27(4):861-8. PubMed ID: 19262408
[TBL] [Abstract][Full Text] [Related]
6. [Is leptin an independent risk factor for development of left ventricular hypertrophy in obese hypertensive patients?].
Kiliç T
Anadolu Kardiyol Derg; 2008 Oct; 8(5):347-9. PubMed ID: 18849225
[No Abstract] [Full Text] [Related]
7. Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.
Barrios V; Escobar C; Calderon A; Ribas L; Marti D; Asin E
Blood Press; 2008; 17(2):110-5. PubMed ID: 18568700
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
[TBL] [Abstract][Full Text] [Related]
9. Increased QRS voltage in the limb leads.
MacKenzie R
J Insur Med; 2006; 38(3):213-9. PubMed ID: 17076143
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and determinants of electrocardiographic left ventricular hypertrophy among a multiethnic population of postmenopausal women (The Women's Health Initiative).
Oberman A; Prineas RJ; Larson JC; LaCroix A; Lasser NL
Am J Cardiol; 2006 Feb; 97(4):512-9. PubMed ID: 16461048
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of electrocardiographic criteria for left ventricular hypertrophy.
Hsieh BP; Pham MX; Froelicher VF
Am Heart J; 2005 Jul; 150(1):161-7. PubMed ID: 16084164
[TBL] [Abstract][Full Text] [Related]
13. A case of clover-shaped left ventricular non-compaction.
Kurita T; Onishi K; Ogawa T; Kasai A; Sakuma H; Ito M
Eur Heart J; 2008 Feb; 29(4):569. PubMed ID: 17977843
[No Abstract] [Full Text] [Related]
14. [Quantitative repolarization indices in diagnosis of left ventricular hypertrophy in hypertensive patients].
Sakhnova TA; Blinova EV; Sergakova LM; Ataullakhanova DM; Chazova IE
Ter Arkh; 2009; 81(4):13-7. PubMed ID: 19514415
[TBL] [Abstract][Full Text] [Related]
15. Effects of papillary muscles and trabeculae on left ventricular quantification: increased impact of methodological variability in patients with left ventricular hypertrophy.
Janik M; Cham MD; Ross MI; Wang Y; Codella N; Min JK; Prince MR; Manoushagian S; Okin PM; Devereux RB; Weinsaft JW
J Hypertens; 2008 Aug; 26(8):1677-85. PubMed ID: 18622248
[TBL] [Abstract][Full Text] [Related]
16. Heart rate variability and left ventricular mass in slim children and young adults with hypertension.
Kowalewski M; Baszuk-Stefaniuk E; Urban M; Peczyńska J
Kardiol Pol; 2005 Dec; 63(6):605-10; discussion 611-2. PubMed ID: 16380859
[TBL] [Abstract][Full Text] [Related]
17. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
[TBL] [Abstract][Full Text] [Related]
18. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements.
Sosnowski M; Korzeniowska B; Tendera M
Int J Cardiol; 2006 Jan; 106(3):382-9. PubMed ID: 15996771
[TBL] [Abstract][Full Text] [Related]
20. Prolonged recovery time in the left precordial leads reflects increased left ventricular mass in the hypertensive patients.
Hara H; Niwano S; Ikeda N; Izumi T
J Electrocardiol; 2005 Oct; 38(4):406-11. PubMed ID: 16216619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
